In Vitro activity and clinical pharmacology of new β-lactam and monobactam antimicrobials

Ballard, 1984, Comparison of the effects of mezlocillin, carbenicillin and placebo on normal hemostasis, Antimicrob. Agents Chemother., 75, 153, 10.1128/AAC.25.2.153 Barriere, 1984, Third-generations: a critical evaluation, Clin Pharm., 3, 351 Barriere, 1982, Ceforanide: antibacterial activity, pharmacology, and clinical efficacy, Pharmacotherapy, 2, 322, 10.1002/j.1875-9114.1982.tb03208.x Barry, 1980, In vitro activity of mezlocillin and azlocillin compared to that of four other penicillins and two aminoglycosides, Cleve. Clin. Q., 47, 311, 10.3949/ccjm.47.4.311 Bergan, 1981, Overview of acylureidopenicillin pharmacokinetics, Scand. J. Infect. Dis., 29, 33 Chandrasekar, 1984, Enterococcal superinfection and colonization with aztreonam therapy, Antimicrob. Agents Chemother., 26, 280, 10.1128/AAC.26.2.280 Drusano, 1984, Multipledose pharmacokinetics of imipenemcilastatin, Antimicrob. Agents Chemother., 26, 715, 10.1128/AAC.26.5.715 Drusano, 1984, The acylampicillins: mezlocillin, piperacillin, and azlocillin, Rev. Infect. Dis., 6, 13, 10.1093/clinids/6.1.13 Dudley, 1984, Review of cefonicid, a long-acting cephalosporin, Clin. Pharm., 3, 23 Dudley, 1984, Pharmacokinetics of total and unbound cefonicid, Clin. Pharmacol. Ther., 35, 236 Dudley, 1982, Effects of protein binding on the pharmacology of cephalosporins Dudley, 1983, In vitro activity of cefonicid, ceforanide and cefazolin against Staphylococcus aureus and Staphylococcus epidermidis and the effect of human scrum, J. Infect. Dis., 148, 178, 10.1093/infdis/148.1.178 Jones, 1982, Antimicrobial activity of desacetyl cefotaxime alone and in combination with cefotaxime: evidence of synergy, Rev. Infect. Dis., 4, S366, 10.1093/clinids/4.Supplement_2.S366 Landesman, 1981, Past and current roles for cephalosporin antibiotics in treatment of meningitis, Am. J. Med., 71, 693, 10.1016/0002-9343(81)90240-0 Lipsky, 1984, Production of hypoprothrombinemia by moxalactam and 1-methyl-5-thiotetrazole in rats, Antimicrob. Agents Chemother., 25, 380, 10.1128/AAC.25.3.380 Moellering, 1982, Enterococcal infections in patients treated with moxalactam, Rev. Infect. Dis., 4, S708, 10.1093/clinids/4.Supplement_3.S708 Neu, 1982, The new beta-lactamase stable cephalosporins, Ann. Intern. Med., 97, 408, 10.7326/0003-4819-97-3-408 Neu, 1981, Antibacterial activity of a monocyclic beta-lactam SQ 26,776, J. Antimicrob. Chemother., 8, 111, 10.1093/jac/8.suppl_E.111 Sanders, 1983, Emergence of resistance during therapy with the newer beta-lactam antibiotics: role of inducible beta-lactamases and implications for the future, Rev. Infect. Dis., 5, 639, 10.1093/clinids/5.4.639 Simon, 1980, Clinical trial of piperacillin and acquisition of resistance by Pseudomonas and clinical relapse, Antimicrob. Agents Chemother., 18, 167, 10.1128/AAC.18.1.167 Smith, 1984, Cefsulodin and ceftazidine, two antipseudomanal cephalosporins, Clin. Pharm., 3, 373 Smith, 1983, Cefuroxine: antimicrobial activity, pharmacology, and clinical efficacy, Ther. Drug Monit., 5, 149, 10.1097/00007691-198306000-00001 Smith, 1983, Hypoprothrombinemia and platelet dysfunction caused by cephalosporin and oxalactam antibiotics, J. Antimicrob. Chemother., 11, 496, 10.1093/jac/11.6.496 Somani, 1983, The effects of mezlocillin, ticareillin, and placebo on blood coagulation and bleeding times in normal volunteers, J. Antimicrob. Chemother., 11, 33, 10.1093/jac/11.suppl_C.33 Swabb, 1982, Single-dose pharmacokinetics of the monobactam aztreonam (SQ 26,776) in healthy subjects, Antimicrob. Agents Chemother., 21, 944, 10.1128/AAC.21.6.944 Winston, 1984, Imipenem therapy of Pseudomonas aeruginosa and other serious bacterial infections, Antimicrob. Agents Chemother., 26, 673, 10.1128/AAC.26.5.673